Chen J, Diouf I, Taylor BV, Kalincik T, et al. Superior effects of natalizumab versus other DMTs on patient-reported outcomes in people with multiple sclerosis. J Neurol Neurosurg Psychiatry 2022 Jul 28. pii: jnnp-2022-329223.
PMID: 35902227